A bipartisan group of 32 attorneys general is urging the Supreme Court to grant them more regulatory power over pharmacy benefit managers. 

AdventHealth Shawnee Mission in Merriam, Kan., announced a $35,000 partnership with Pharmacy of Grace, a nonprofit in the Kansas City metropolitan area that provides pharmacy services to uninsured or underinsured patients.

Team Cuban Card, an offering from Mark Cuban Cost Plus Drug Co., is now accepted at Food Lion, Giant Food, Hannaford and Stop & Shop. 

Tirzepatide, the main ingredient for Eli Lilly's Mounjaro and Zepbound, omitted the presence of metabolic dysfunction-associated steatohepatitis in a phase 2 study, the drugmaker said June 8. The trial results could precede another indication for the popular drugs. 

On June 10, a panel of FDA advisors voted 11-0 in favor of donanemab, an experimental Alzheimer's disease treatment from Eli Lilly. 

Between 2022 and 2023, the average hospital pharmacist saw a 4% salary increase, according to a Drug Channels report.

On June 10, Moderna said its experimental combination vaccine for COVID-19 and influenza surpassed the efficacy of existing shots in a phase 3 trial. 

Louisville, Ky.-based Baptist Health named Rachel Connors, PharmD, as the pharmacy director of its hospital in New Albany, Ind.

Artificial intelligence has already started to transform hospital and health system functions, communications, imaging and other operations, but what role could it have in pharmacies?

Cleveland Clinic's new chief pharmacy officer has a simple goal: No surprises.

Minnesota is the seventh state to approve a new 340B contract pharmacy law that forbids drug manufacturers and distributors from limiting access to medications for hospitals and health systems serving uninsured and underinsured populations.

Bristol Myers Squibb, one of 12 pharmaceutical and health service companies in the Fortune 500 list, plans to lay off 863 employees in Lawrenceville, N.J., according to recently filed WARN notices. 

Beginning June 18, a newly finalized rule from the Health Resources and Services Administration will take effect and change how the resolution of disputes within the 340B program is handled.

CEOs of two U.S. health systems testified June 4 before a House subcommittee on the oversight of the 340B drug pricing program, advocating for the preservation of the protections that have been in place for hospitals and patients since 1992.

After a medication error or an unexpected patient outcome, it is common for practitioners to question themselves and feel shame and guilt, according to the American Society of Health-System Pharmacists. 

All retail, home delivery and specialty pharmacies operated by Ascension resumed normal operations as of June 4, according to the St. Louis-based organization recovering from a cyberattack. 

Additional updates are needed to reduce the risk of medication errors associated with automated dispensing cabinets, the Institute for Safe Medication Practices said May 31. 

Louisville, Ky.-based Baptist Health is slated to open one of the nation's first autonomous pharmacy centers June 5. 

The FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31.

The growth and complexity of biosimilar agents for infusion therapy is generating a need for effective tools to optimize product selection and manage costs. Frequent changes in payer policies lead to frustrating delays in the authorization process and create obstacles that impact patient care.